|View printer-friendly version|
LifeMap Sciences also holds the exclusive, worldwide licenses to market GeneCards® and PanDaTox also developed by the
“LifeMap Sciences is now making the most comprehensive cell biology, genomics, and pathology databases for medical research available from a single source,” stated
LifeMap Sciences’ (www.lifemapsc.com) core technology and business is based on its integrated database suite, The go-to discovery and marketing platform for biomedical and stem-cell research. This platform will include GeneCards®: the leading human gene database; the LifeMap™ database of embryonic development, stem cell research and regenerative medicine; and MalaCards, the human disease database. LifeMap Sciences also markets PanDaTox, a recently developed, searchable database that can aid in the discovery of new antibiotics and biotechnologically beneficial products.
In addition to database offerings,
In a therapeutic discovery collaboration with
Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for
To receive ongoing
Peter Garcia, 510-521-3390 ext. 367
Chief Financial Officer
Judith Segall, 510-521-3390 ext. 301
LifeMap Sciences, Inc.
Kenneth Elsner, 781-826-7719